8
THE JOURNAL OF UROLOGY®
19 RISK OF MALNUTRITION IN UROLOGICAL PATIENTS Alexander Karl*, Peter Rittler, Alexander Buchner, Munich, Germany; Vincent Fradet, San Francisco, CA; Sebastian Walther, Christian G Stief, Munich, Germany INTRODUCTION AND OBJECTIVE: For different diseases and medical fields malnutrition has been shown to be associated with an impaired patient outcome. In general there is a lack of data on the prevalence of malnutrition in urological patients. The assessment of the risk for malnutrition is needed in order to raise awareness of this condition and to initiate nutrition therapy if needed. METHODS: Nutritional state was assessed prospectively using the Nutritional Risk Screening test (NRS 2002). Eight-hundred and ninety-seven patients were evaluated at a urological department in Germany. The Nutritional risk screening started in January 2007 and closed in July 2007. Seven-hundred fifty-one (84%) patients were male and one-hundred forty-six (16%) were female; the median age was sixty-six yrs (18-98 yrs). Four-hundred forty-one patients presented with benign disease and four-hundred fifty-six patients with a malignant disease. RESULTS: Based on the NRS a severe risk of malnutrition was diagnosed in 144 (16%) patients (NRS Score > 3). The NRS score was assessed at score 0 (no malnutrition), 1-2 (risk for malnutrition) and 3-5 (severe risk for malnutrition) in 45, 708 and 144 patients, respectively. As significant risk factors were detected - age and malignant disease (p<0.001). Also type of surgery was significantly associated with a subsequent risk of malnutrition (p<0.001). Gender and body mass index had no significant influence. CONCLUSIONS: In this study 16% of urological patients were at severe risk of malnutrition according to the NRS 2002. Higher age, type of procedure and malignant disease were associated significantly with a higher risk for malnutrition. Further evaluation of these patients and adequate nutritional supportive therapy should be considered in these patients in order to may optimize their clinical outcome.
Vol. 181, No. 4, Supplement, Saturday, April 25, 2009
1; there was a significant difference between subjects with and without nocturia (p<0.0002). The multivariate hazard ratios (95% confidence intervals) for mortality with nocturia were 2.68(1.12-6.43). CONCLUSIONS: We conclude that there is a significantly increased mortality rate associated with nocturia (q2 voids/night), even after adjustment for several factors which may contribute to mortality.
Hazard ratios of mortality according to nocturia
ASSOCIATION BETWEEN NOCTURIA AND MORTALITY IN A COMMUNITY-DWELLING ELDERLY POPULATION AGED 70 YEARS AND OVER: RESULTS OF A 3-YEAR PROSPECTIVE COHORT STUDY IN JAPAN Haruo Nakagawa*, Kaijun Niu, Atsushi Hozawa, Yoshihiro Ikeda, Yasuhiro Kaiho, Kaori Masuda-Ohmori, Ryoichi Nagatomi, Ichiro Tsuji, Yoichi Arai, Sendai, Japan INTRODUCTION AND OBJECTIVE: Nocturia is a common problem which increases with age. It is often a result of an overproduction of urine at night (nocturnal polyuria), but may also be associated with several physiological conditions, such as cardiovascular disease, diabetes mellitus, sleep apnea syndrome, renal dysfunction, lower urinary tract dysfunction and sleep disorders. An increased mortality rate has been reported with nocturia, and may be related to these associated conditions, or independently to nocturia. This study aimed to evaluate the association between nocturia and mortality in a community-based elderly population. METHODS: We conducted a Comprehensive Geriatric Assessment of all residents aged q70 years in 2003 in an urban district of north Japan. The population-based cross-sectional survey was conducted using an extensive health interview for each participant. Mortality over 3 years was investigated using data from the national health insurance system. Differences in survival stratified by presence/ absence of nocturia (q2 voids/night) were assessed with Kaplan-Meier curves, and statistical significance was calculated with the log-rank test. The risk of mortality with or without nocturia was compared using a time varying multivariate Cox proportional hazard model. RESULTS: 788 people were included in the study (28.9% participation rate; 429 females, 359 males; mean age 74.9 ± 4.77 [range: 70-97]). Kaplan-Meier curves representing mortality are shown in Figure
a1
q2
15685.4
13391.8
No. of cases
7
24
Model 1*
1.00
4.02(1.73-9.32)
Model 2**
1.00
2.88(1.21-6.84)
Model 3***
1.00
2.68(1.12-6.43)
Hazard Ratio (95% Confidence Interval)
Source of Funding: None
20
night time frequency Person-months of follow up
**: Adjusted for age, sex, BMI, ***: Adjusted for model 2 + diabetes, hypertension, history of coronary heart disease, nephropathy, alcohol consumption, use of tranquilizers, use of hypnotics, use of diuretics, and history of delivery.
Source of Funding: Chiyoda Health Foundation and The Universe Foundation
Adrenal: Benign Disease, Tumors, Physiology & Pharmacology, Surgery Podium 1 Saturday, April 25, 2009
1:00 pm - 3:00 pm
21 ADRENOCORTICAL CARCINOMA: A 30-YEAR EXPERIENCE AT A SINGLE INSTITUTION Marcos Lucon*, Maria Adelaide A Pereira, Daniel Soares Freire, Antonio M Lucon, Maria Candida Fragoso, Miguel Srougi, Berenice Bilharinho Mendonca, Sao Paulo, Brazil INTRODUCTION AND OBJECTIVE: adrenocortical carcinoma is a rare disease associated with dismal prognosis. The results of a large retrospective cohort comprising 100 patients with adrenocortical carcinoma treated at a single institution are reported. METHODS: from January 1976 to July 2008, 100 patients with adrenocortical carcinoma were evaluated. The diagnosis was established when three or more patterns of Weiss´s criteria were presented or identification of metastasis when tumor tissue was not available for pathologic examination. The age at diagnosis, tumor size, stage, functional